| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Qi Huang, Feng Li, Song Zha. Spotlight on MuSK positive myasthenia gravis: clinical characteristics, treatment and outcomes. BMC neurology. vol 22. issue 1. 2022-03-05. PMID:35246057. |
spotlight on musk positive myasthenia gravis: clinical characteristics, treatment and outcomes. |
2022-03-05 |
2023-08-13 |
Not clear |
| Michael P Skolka, Chris Lamb, Christopher J Klein, Devon I Rubin, Ruple S Laughli. Myotonia in MuSK Myasthenia Gravis: A Unique Electrodiagnostic Finding. Journal of clinical neuromuscular disease. vol 23. issue 3. 2022-02-21. PMID:35188919. |
myotonia in musk myasthenia gravis: a unique electrodiagnostic finding. |
2022-02-21 |
2023-08-13 |
Not clear |
| Caterina Maria Gambino, Luisa Agnello, Bruna Lo Sasso, Concetta Scazzone, Rosaria Vincenza Giglio, Giuseppina Candore, Anna Maria Ciaccio, Vincenzo Di Stefano, Filippo Brighina, Matteo Vidali, Marcello Ciacci. Comparative Analysis of BIOCHIP Mosaic-Based Indirect Immunofluorescence with Enzyme-Linked Immunosorbent Assay for Diagnosing Myasthenia Gravis. Diagnostics (Basel, Switzerland). vol 11. issue 11. 2021-11-30. PMID:34829445. |
the detection of anti-acetylcholine receptor (achr) and anti-muscle-specific tyrosine kinase (musk) antibodies is useful in myasthenia gravis (mg) diagnosis and management. |
2021-11-30 |
2023-08-13 |
Not clear |
| Ying Tan, Li Zhu, Liying Cui, Yuzhou Gua. Differential Expression of miRNA in the Peripheral Blood Mononuclear Cells in Myasthenia Gravis with Muscle-Specific Receptor Tyrosine Kinase Antibodies. Critical reviews in eukaryotic gene expression. vol 31. issue 2. 2021-11-08. PMID:34347975. |
clinically, the four mirnas that were validated are not correlated to musk antibody titers and quantitative myasthenia gravis score. |
2021-11-08 |
2023-08-13 |
Not clear |
| Sijia Zhao, Kai Zhang, Kaixi Ren, Jiarui Lu, Chao Ma, Cong Zhao, Zhuyi Li, Jun Gu. Clinical features, treatment and prognosis of MuSK antibody-associated myasthenia gravis in Northwest China: a single-centre retrospective cohort study. BMC neurology. vol 21. issue 1. 2021-11-05. PMID:34732168. |
clinical features, treatment and prognosis of musk antibody-associated myasthenia gravis in northwest china: a single-centre retrospective cohort study. |
2021-11-05 |
2023-08-13 |
Not clear |
| Paul W Wirt. Dysphagia and respiratory failure in an HIV patient: MuSK myasthenia gravis. Acta neurologica Belgica. vol 120. issue 6. 2021-11-01. PMID:32851549. |
dysphagia and respiratory failure in an hiv patient: musk myasthenia gravis. |
2021-11-01 |
2023-08-13 |
Not clear |
| C Zografou, A G Vakrakou, P Stathopoulo. Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders. Frontiers in immunology. vol 12. 2021-10-28. PMID:34220839. |
in myasthenia gravis with predominantly igg4 autoantibodies against muscle-specific kinase (musk), it has been observed that one-time cd20 |
2021-10-28 |
2023-08-13 |
Not clear |
| Ashley Santilli, Derek Stit. MuSK Myasthenia Gravis Presenting with Bilateral Vocal Cord Abduction Paresis: A Case Report and Literature Review. The neurologist. vol 26. issue 5. 2021-10-28. PMID:34491934. |
musk myasthenia gravis presenting with bilateral vocal cord abduction paresis: a case report and literature review. |
2021-10-28 |
2023-08-13 |
Not clear |
| Ashley Santilli, Derek Stit. MuSK Myasthenia Gravis Presenting with Bilateral Vocal Cord Abduction Paresis: A Case Report and Literature Review. The neurologist. vol 26. issue 5. 2021-10-28. PMID:34491934. |
approximately 39% to 49% of patients with previously diagnosed acetylcholine receptor antibody-negative myasthenia gravis have been found to be muscle-specific tyrosine kinase (musk) antibody positive. |
2021-10-28 |
2023-08-13 |
Not clear |
| Dana L E Vergoossen, Jaap J Plomp, Christoph Gstöttner, Yvonne E Fillié-Grijpma, Roy Augustinus, Robyn Verpalen, Manfred Wuhrer, Paul W H I Parren, Elena Dominguez-Vega, Silvère M van der Maarel, Jan J Verschuuren, Maartje G Huijber. Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis. Proceedings of the National Academy of Sciences of the United States of America. vol 118. issue 13. 2021-10-20. PMID:33753489. |
here, we demonstrate that this process amplifies autoantibody pathogenicity in a classic igg4-mediated autoimmune disease: muscle-specific kinase (musk) myasthenia gravis. |
2021-10-20 |
2023-08-13 |
mouse |
| Feza Deymee. Myasthenia gravis: MuSK MG, late-onset MG and ocular MG. Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology. vol 39. issue 4. 2021-10-18. PMID:33458590. |
myasthenia gravis: musk mg, late-onset mg and ocular mg. myasthenia gravis (mg) is an autoimmune disease of the neuromuscular junction which affects all striated muscles, resulting in fluctuating weakness. |
2021-10-18 |
2023-08-13 |
human |
| Dana L E Vergoossen, Roy Augustinus, Maartje G Huijber. MuSK antibodies, lessons learned from poly- and monoclonality. Journal of autoimmunity. vol 112. 2021-10-12. PMID:32505442. |
the role of antibodies in musk-related research got an extra dimension when autoantibodies to musk were found to cause myasthenia gravis (mg) in 2001. |
2021-10-12 |
2023-08-13 |
Not clear |
| Umberto Basile, Cecilia Napodano, Francesca Gulli, Krizia Pocino, Riccardo Di Santo, Laura Todi, Valerio Basile, Carlo Provenzano, Gabriele Ciasca, Mariapaola Marin. Laboratory Investigation of Hybrid IgG4 k/λ in MuSK Positive Myasthenia Gravis. International journal of molecular sciences. vol 22. issue 17. 2021-10-12. PMID:34502051. |
laboratory investigation of hybrid igg4 k/λ in musk positive myasthenia gravis. |
2021-10-12 |
2023-08-13 |
Not clear |
| Umberto Basile, Cecilia Napodano, Francesca Gulli, Krizia Pocino, Riccardo Di Santo, Laura Todi, Valerio Basile, Carlo Provenzano, Gabriele Ciasca, Mariapaola Marin. Laboratory Investigation of Hybrid IgG4 k/λ in MuSK Positive Myasthenia Gravis. International journal of molecular sciences. vol 22. issue 17. 2021-10-12. PMID:34502051. |
myasthenia gravis with antibodies (abs) against the muscle-specific tyrosine kinase (musk) is a rare autoimmune disorder (ad) of the neuromuscular junction (nmj) and represents a prototype of ad with proven igg4-mediated pathogenicity. |
2021-10-12 |
2023-08-13 |
Not clear |
| Anna Modoni, Alessia Mastrorosa, Gregorio Spagni, Amelia Evol. Cholinergic hyperactivity in patients with myasthenia gravis with MuSK antibodies: A neurophysiological study. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. vol 132. issue 8. 2021-10-11. PMID:34147009. |
cholinergic hyperactivity in patients with myasthenia gravis with musk antibodies: a neurophysiological study. |
2021-10-11 |
2023-08-13 |
Not clear |
| A Uzawa, S Kuwabara, S Suzuki, T Imai, H Murai, Y Ozawa, M Yasuda, Y Nagane, K Utsugisaw. Roles of cytokines and T cells in the pathogenesis of myasthenia gravis. Clinical and experimental immunology. vol 203. issue 3. 2021-09-27. PMID:33184844. |
myasthenia gravis (mg) is characterized by muscle weakness and fatigue caused by the presence of autoantibodies against the acetylcholine receptor (achr) or the muscle-specific tyrosine kinase (musk). |
2021-09-27 |
2023-08-13 |
Not clear |
| Yuka Yamaguchi, Takeshi Fujimoto, Nobutaka Hayashi, Daiji Torimura, Yasuhiro Maeda, Akira Tsujin. [A case of elderly-onset myasthenia gravis mimicking stroke with dysarthria and left upper extremity paresis]. Rinsho shinkeigaku = Clinical neurology. vol 61. issue 4. 2021-09-22. PMID:33762493. |
assessment of the cause of the respiratory failure revealed positive muscle-specific kinase (musk) antibodies, which suggested myasthenia gravis (mg). |
2021-09-22 |
2023-08-13 |
Not clear |
| Dana L E Vergoossen, Arlin Keo, Ahmed Mahfouz, Maartje G Huijber. Timing and localization of myasthenia gravis-related gene expression. The European journal of neuroscience. vol 54. issue 4. 2021-09-10. PMID:34228850. |
myasthenia gravis (mg) is an acquired autoimmune disorder caused by autoantibodies binding acetylcholine receptors (achr), muscle-specific kinase (musk), agrin or low-density lipoprotein receptor-related protein 4 (lrp4). |
2021-09-10 |
2023-08-13 |
human |
| Carolyn Tsai, James F Howard, Anahit Mehrabya. A Case of MuSK Myasthenia Gravis Presenting With Persistent Respiratory Insufficiency. Journal of clinical neuromuscular disease. vol 23. issue 1. 2021-08-26. PMID:34431800. |
a case of musk myasthenia gravis presenting with persistent respiratory insufficiency. |
2021-08-26 |
2023-08-13 |
Not clear |
| Carolyn Tsai, James F Howard, Anahit Mehrabya. A Case of MuSK Myasthenia Gravis Presenting With Persistent Respiratory Insufficiency. Journal of clinical neuromuscular disease. vol 23. issue 1. 2021-08-26. PMID:34431800. |
muscle-specific kinase (musk) antibody is seen in 4%-10% of patients with myasthenia gravis (mg), with 40% of these patients reporting bulbar weakness as the initial symptom. |
2021-08-26 |
2023-08-13 |
Not clear |